The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Differential expression of thymosin β‐10 by early passage and senescent vascular endothelium is modulated by VPF/VEGF: evidence for senescent endothelial cells in vivo at sites of atherosclerosis
Abstract
VPF/VEGF acts selectively on the vascular endothelium to enhance permeability, induce cell migration and division, and delay replicative senescence. To understand the changes in gene expression during endothelial senescence, we investigated genes that were differentially expressed in early vs. late passage (senescent) human dermal endothelial cells (HDMEC) using cDNA array hybridization. Early passage HDMEC cultured with or without VPF/VEGF overexpressed 9 and underexpressed 6 genes in comparison with their senescent counterparts. Thymosin β‐10 expression was modulated by VPF/VEGF and was strikingly down‐regulated in senescent EC. The β‐thymosins are actin G‐sequestering peptides that regulate actin dynamics and are overexpressed in neoplastic transformation. We have also identified senescent EC in the human aorta at sites overlying atherosclerotic plaques. These EC expressed senescence‐associated neutral β‐galactosidase and, in contrast to adventitial microvessel endothelium, exhibited weak staining for thymosin β‐10. ISH performed on human malignant tumors revealed strong thymosin β‐10 expression in tumor blood vessels. This is the first report that Tβ‐10 expression is significantly reduced in senescent EC, that VPF/VEGF modulates thymosin β‐10 expression, and that EC can become senescent in vivo . The reduced expression of thymosin β‐10 may contribute to the senescent phenotype by reducing EC plasticity and thus impairing their response to migratory stimuli.—Vasile, E., Tomita, Y., Brown, L. F., Kocher, O., Dvorak, H. F. Differential expression of thymosin Β‐10 by early passage and senescent vascular endothelium is modulated by VPF/VEGF: evidence for senescent endothelial cells in vivo at sites of atherosclerosis. FASEB J. 15, 458‐466 (2001)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“and have been found at sites of age-related pathologies such as osteoarthritis and atherosclerosis [ 28 – 30 ].”
From Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor (2008) · cites this paper as [29]
In the citing paper
“Although some aged tissues contain less than one or only a few percent of senescent cells [ 29 , 66 , 71 ], others can accumulate as many as 15% senescent cells [ 65 , 72 ].”
From Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor (2008) · cites this paper as [29]
In the citing paper
“Additional clinical evidence of the involvement of cellular senescence in the atherosclerotic vessel wall in the general population comes from post-mortem histological analysis,96,131–134 that showed that senescent EC and VSMC accumulate substantially more in atherosclerotic than in physiologically aged healthy arteries.96,131–134”
From Senescence-induced inflammation: an important player and key therapeutic target in atherosclerosis (2020) · cites this paper as [133]
Citations
Cites
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477 · cited 2×
“ogy and expression of neutral b galactosidase (9, 10).”
BackgroundMarkwell, M. A. K., Haas, S. M., Bieber, L. L., & Tolbert, N. E. (1978) · Analytical Biochemistry · doi:10.1016/0003-2697(78)90586-9 · Cited by 6,458 · cited 1×
“Protein content was measured by a modified Lowry assay (29).”
MethodDvorak, H. F., Brown, L. F., Detmar, M. J., & Dvořàk, A. M. (1995) · Europe PMC (PubMed Central) · Cited by 3,115
Self-citationBilheimer, D. W., Eisenberg, S., & Levy, R. I. (1972) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(72)90034-3 · Cited by 1,818
Low Density Lipoprotein Oxidation and Its Pathobiological Significance
Steinberg, D. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.34.20963 · Cited by 1,642 · cited 2×
“subsequently internalized by receptor-mediated endocytosis and are then degraded in lysosomes (36, 37).”
Background[19] Receptor-mediated endocytosis of low-density lipoprotein in cultured cells
Goldstein, J. L., Basu, S. K., & Brown, M. S. (1983) · Methods in Enzymology · doi:10.1016/0076-6879(83)98152-1 · Cited by 1,624 · cited 2×
“DiI-acetylated-LDL (DiI-Ac-LDL) was prepared as described previously (31) or was purchased from Biomedical Technologies Inc.”
MethodHMEC-1: Establishment of an Immortalized Human Microvascular Endothelial Cell Line
Ades, E. W., Candal, F. J., Swerlick, R. A., George, V. G., Summers, S., Bosse, D. C., & Lawley, T. J. (1992) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12613748 · Cited by 1,265 · cited 1×
“large T antigen (4, 5), activation of the telomerase gene”
BackgroundKrieger, M., & Krieger, J. (1994) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.63.070194.003125 · Cited by 1,160 · cited 1×
“subsequently internalized by receptor-mediated endocytosis and are then degraded in lysosomes (36, 37).”
BackgroundSeparation of plasma lipoproteins by density-gradient ultracentrifugation
Redgrave, T. G., Roberts, D. C. K., & West, C. E. (1975) · Analytical Biochemistry · doi:10.1016/0003-2697(75)90488-1 · Cited by 1,107 · cited 1×
“Low density lipoproteins (LDL) were separated from human plasma as described previously (27, 28).”
MethodBrown, L. F., Yeo, K. T., Berse, B., Yeo, T. K., Senger, D. R., Dvorak, H. F., & van de Water, L. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.5.1375 · Cited by 878 · cited 1×
“In situ hybridization was performed as described previously (35).”
MethodSelf-citation
Cited by
Cellular senescence: when bad things happen to good cells
Campisi, J., & d'Adda di Fagagna, F. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2233 · Cited by 4,441
Coppé, J.-P., Patil, C. K., Rodier, F., Sun, Y., Muñoz, D. P., Goldstein, J., Nelson, P. S., Desprez, P.-Y., & Campisi, J. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060301 · Cited by 302
“osteoarthritis and atherosclerosis [28–30].”
BackgroundInflammatory networks during cellular senescence: causes and consequences.
Freund, A., Orjalo, A. V., Desprez, P.-Y., & Campisi, J. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.03.003 · Cited by 1,354
Fat tissue, aging, and cellular senescence
Tchkonia, T., Morbeck, D. E., Von Zglinicki, T., Van Deursen, J., Lustgarten, J., Scrable, H., Khosla, S., Jensen, M. D., & Kirkland, J. L. (2010) · Aging Cell · doi:10.1111/j.1474-9726.2010.00608.x · Cited by 1,094
DNA damage response and cellular senescence in tissues of aging mice
Wang, C., Jurk, D., Maddick, M., Nelson, G., Martin‐Ruiz, C., & Von Zglinicki, T. (2009) · Aging Cell · doi:10.1111/j.1474-9726.2009.00481.x · Cited by 696
“Examples are vascular aging and atherosclerosis (Fenton et al., 2001; Vasile et al., 2001; Minamino et al., 2002), liver cirrhosis (Wiemann et al., 2002) and osteoarthritis (Martin & Buckwalter, 2002).”
BackgroundParrinello, S., Coppe, J.-P., Krtolica, A., & Campisi, J. (2005) · Journal of Cell Science · doi:10.1242/jcs.01635 · Cited by 631
“…human and rodent cells with senescent characteristics accumulate in vivo with age and at sites of agerelated pathology, including hyperplastic and premalignant lesions (Choi et al., 2000; Dimri et al., 1995; Krtolica and Campisi, 2002; Melk et al., 2003; Paradis et al., 2001; Vasile et al., 2001).”
BackgroundMatthews, C., Gorenne, I., Scott, S., Figg, N., Kirkpatrick, P., Ritchie, A., Goddard, M., & Bennett, M. (2006) · Circulation Research · doi:10.1161/01.res.0000233315.38086.bc · Cited by 615
Secretion of vascular endothelial growth factor by primary human fibroblasts at senescence
Coppé, J.-P., Kauser, K., Campisi, J., & Beauséjour, C. M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603307200 · Cited by 604
Vascular Cell Senescence: Contribution to Atherosclerosis
Minamino, T., & Komuro, I. (2007) · Circulation Research · doi:10.1161/01.res.0000256837.40544.4a · Cited by 542
Invited Review: Theories of aging
Weinert, B. T., & Timiras, P. S. (2003) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00288.2003 · Cited by 528
“Several studies suggest that atherosclerosis results from senescent changes in arterial endothelial cells (15, 26, 94).”
Cancer and ageing: rival demons?
Campisi, J. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1073 · Cited by 512
Kurz, D. J., Decary, S., Hong, Y., Trivier, E., Akhmedov, A., & Erusalimsky, J. D. (2004) · Journal of Cell Science · doi:10.1242/jcs.01097 · Cited by 499
“In addition, we and others have shown that senescent endothelial cells are present in vivo in pathophysiological contexts (Fenton et al., 2001; Vasile et al., 2001; Minamino et al., 2002) known to be associated with increased oxidative stress (Griendling and Alexander, 1997).”
BackgroundVascular endothelial senescence: from mechanisms to pathophysiology
Erusalimsky, J. D. (2009) · Journal of Applied Physiology · doi:10.1152/japplphysiol.91353.2008 · Cited by 399
“Similarly, other laboratories demonstrated the presence of senescent endothelial cells overlying atherosclerotic plaques of human aorta and coronary arteries (57, 90) and in the aortae of diabetic rats (12).”
Cellular senescence and organismal aging
Jeyapalan, J. C., & Sedivy, J. M. (2008) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2008.04.001 · Cited by 346
Mechanisms of cellular senescence in human and mouse cells.
Itahana, K., Campisi, J., & Dimri, G. P. (2004) · Biogerontology · doi:10.1023/b:bgen.0000017682.96395.10 · Cited by 338
“Senescent cells have also been detected at sites of age-related pathology, such as benign hyperplastic prostate (Choi et al. 2000) and atherosclerotic lesions (Vasile et al. 2001).”
BackgroundCevenini, E., Monti, D., & Franceschi, C. (2013) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e32835ada13 · Cited by 317
“In particular, cells expressing senescent markers have been found in vivo at sites of chronic age-related pathologies such as osteoarthritis and atherosclerosis and they contribute to the ageing process [22,23], reinforcing the link between senescent cells, ageing and age-related diseases.”
BackgroundKunieda, T., Minamino, T., Nishi, J.-I., Tateno, K., Oyama, T., Katsuno, T., Miyauchi, H., Orimo, M., Okada, S., Takamura, M., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.626606 · Cited by 302
Cancer and aging: a model for the cancer promoting effects of the aging stroma
Krtolica, A., & Campisi, J. (2002) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(02)00053-5 · Cited by 295
DNA end joining becomes less efficient and more error-prone during cellular senescence
Seluanov, A., Mittelman, D., Pereira-Smith, O. M., Wilson, J. H., & Gorbunova, V. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400726101 · Cited by 278
Cellular senescence in vivo: Its relevance in ageing and cardiovascular disease
Erusalimsky, J. D., & Kurz, D. J. (2005) · Experimental Gerontology · doi:10.1016/j.exger.2005.04.010 · Cited by 252
Cellular Senescence: Molecular Mechanisms, In Vivo Significance, and Redox Considerations
Muller, M. (2009) · Antioxidants & Redox Signaling · doi:10.1089/ars.2008.2104 · Cited by 238
Disturbed Flow Promotes Endothelial Senescence via a p53-Dependent Pathway
Warboys, C. M., de Luca, A., Amini, N., Luong, L., Duckles, H., Hsiao, S., White, A., Biswas, S., Khamis, R., Chong, C. K., et al. (2014) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.114.303415 · Cited by 227
Alterations in microRNA expression in stress-induced cellular senescence
Li, G., Luna, C., Qiu, J., Epstein, D. L., & Gonzalez, P. (2009) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2009.09.002 · Cited by 219
“While cellular senescence is considered a protective mechanism against cancer, it has also been hypothesized that the progressive accumulation of senescent cells in some tissues may contribute to several age-related diseases and organismal aging (Aikata et al., 2000; Castro et al., 2003, 2004; Flanary et al., 2007; Ki…”
BackgroundCellular senescence and apoptosis: how cellular responses might influence aging phenotypes
Campisi, J. (2003) · Experimental Gerontology · doi:10.1016/s0531-5565(02)00152-3 · Cited by 218
“For example, atherosclerosis has been proposed to be initiated by the secretions produced by senescent endothelial cells (Chang and Harley, 1995; Vasile et al., 2001).”
BackgroundHan, Y., & Kim, S. Y. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-022-00906-w · Cited by 201
Identification of Cholesterol-Regulating Genes by Targeted RNAi Screening
Bartz, F., Kern, L., Erz, D., Zhu, M., Gilbert, D., Meinhof, T., Wirkner, U., Erfle, H., Muckenthaler, M., Pepperkok, R., et al. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.05.009 · Cited by 198
Rössig, L., Li, H., Fisslthaler, B., Urbich, C., Fleming, I., Förstermann, U., Zeiher, A. M., & Dimmeler, S. (2002) · Circulation Research · doi:10.1161/01.res.0000037983.07158.b1 · Cited by 198
Vascular smooth muscle cell senescence in atherosclerosis
GORENNE, I., KAVURMA, M., SCOTT, S., & BENNETT, M. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.06.004 · Cited by 196
“SAßG-positive cells are detected in both the endothelium and intimal VSMCs of advanced human atherosclerotic plaques, but not in the vessel media [28,29], suggesting that vessel wall senescence may be a feature of advanced plaques.”
Senescence-induced inflammation: an important player and key therapeutic target in atherosclerosis
Stojanović, S. D., Fiedler, J., Bauersachs, J., Thum, T., & Sedding, D. G. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz919 · Cited by 188
Senescence-Associated β-Galactosidase Detection in Pathology
Valieva, Y., Ivanova, E., Fayzullin, A., Kurkov, A., & Igrunkova, A. (2022) · Diagnostics · doi:10.3390/diagnostics12102309 · Cited by 182
“The endothelium covering nearby regions of relatively normal aorta was SA-β-gal-negative [41]”
BackgroundPathology and biology of radiation-induced cardiac disease
Tapio, S. (2016) · Journal of Radiation Research · doi:10.1093/jrr/rrw064 · Cited by 175
Rippe, C., Blimline, M., Magerko, K. A., Lawson, B. R., LaRocca, T. J., Donato, A. J., & Seals, D. R. (2012) · Experimental Gerontology · doi:10.1016/j.exger.2011.10.004 · Cited by 176
“In atherosclerotic lesions, accumulation of senescent endothelial cells is considered an important factor contributing to the associated arterial dysfunction (Fenton et al., 2001; Minamino et al., 2002; Vasile et al., 2001).”
Aging, tumor suppression and cancer: high wire-act!
Campisi, J. (2005) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2004.09.024 · Cited by 171
“Cells that express SA-Bgal and lack expression of thymosin-b 10, characteristics of senescent endothelial cells in culture have been found at site of atherosclerosis in human aorta (Vasile et al., 2001).”
BackgroundMitochondria, telomeres and cell senescence: Implications for lung ageing and disease
Birch, J., Barnes, P. J., & Passos, J. F. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.10.005 · Cited by 170
Johansson, U., Olsson, A., Gabrielsson, S., Nilsson, B., & Korsgren, O. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)01392-5 · Cited by 166
Glycated Collagen I Induces Premature Senescence-Like Phenotypic Changes in Endothelial Cells
Chen, J., Brodsky, S. V., Goligorsky, D. M., Hampel, D. J., Li, H., Gross, S. S., & Goligorsky, M. S. (2002) · Circulation Research · doi:10.1161/01.res.0000022161.42655.98 · Cited by 163
Krouwer, V. J. D., Hekking, L. H. P., Langelaar-Makkinje, M., Regan-Klapisz, E., & Post, J. (2012) · Vascular Cell · doi:10.1186/2045-824x-4-12 · Cited by 159
“Indeed, senescent cells have been identified in vivo in atherosclerotic tissue [10,11].”
InfluentialNew insight into dyslipidemia‐induced cellular senescence in atherosclerosis
Xiang, Q., Tian, F., Xu, J. R., Du, X., Zhang, S., & Liu, L. (2022) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/brv.12866 · Cited by 180
“Emerging evidence indicates the existence of various types of senescent cells in atherosclerotic arteries, including ECs (Vasile et al., 2001; Minamino et al., 2002; Silva et al., 2017), VSMCs (Gorenne et al.”
BackgroundExtracellular matrix alterations in senescent cells and their significance in tissue homeostasis
Mavrogonatou, E., Pratsinis, H., Papadopoulou, A., Karamanos, N. K., & Kletsas, D. (2019) · Matrix Biology · doi:10.1016/j.matbio.2017.10.004 · Cited by 153
Abbas, M., Jesel, L., Auger, C., Amoura, L., Messas, N., Manin, G., Rumig, C., León‐González, A. J., Ribeiro, T. P., da Silva, G. C., et al. (2016) · Circulation · doi:10.1161/circulationaha.116.017513 · Cited by 171
Tăcutu, R., Budovsky, A., Yanai, H., & Fraifeld, V. E. (2011) · Aging · doi:10.18632/aging.100413 · Cited by 150
Controversial issue: Is it safe to employ mesenchymal stem cells in cell-based therapies?
Lepperdinger, G., Brunauer, R., Jamnig, A., Laschober, G. T., & Kassem, M. S. (2008) · Experimental Gerontology · doi:10.1016/j.exger.2008.07.004 · Cited by 155
“, 2006) as well as in the vascular system (Vasile et al., 2001).”
BackgroundPark, S., Belcastro, E., Hasan, H., Matsushita, K., Marchandot, B., Abbas, M., Toti, F., Auger, C., Jesel, L., Ohlmann, P., et al. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-021-01252-3 · Cited by 163
“Senescent ECs have been observed in human aortic arch [50] and coronary arteries [51] at sites overlapping atherosclerotic plaques characterized by an endothelial dysfunction.”
BackgroundFactors and Pathways Modulating Endothelial Cell Senescence in Vascular Aging
Hwang, H. J., Kim, N., Herman, A. B., Gorospe, M., & Lee, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231710135 · Cited by 149
“Similarly, SA-β-gal-positive ECs exist in human atherosclerotic plaques of the aorta, coronary arteries, and adipose tissues of obese human subjects [26,58,59].”
BackgroundPardal, R., Molofsky, A. V., He, S., & Morrison, S. J. (2005) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2005.70.057 · Cited by 145
“Senescent cells have also been detected at sites of age-related pathology (Vasile et al. 2001), and genes that overcome senescence can enhance the regenerative capacity of tissues exposed to chronic injury (Rudolph et al. 2000).”
BackgroundTsuji, T., Aoshiba, K., & Nagai, A. (2009) · Respiration · doi:10.1159/000268287 · Cited by 134
Park, S., Farooq, M. A., Gaertner, S., Bruckert, C., Qureshi, A. W., Lee, H.-H., Benrahla, D., Pollet, B., Stéphan, D., Ohlmann, P., et al. (2020) · Cardiovascular Diabetology · doi:10.1186/s12933-020-00997-7 · Cited by 138
The Link Between Inflammaging and Degenerative Joint Diseases
Rezuş, E., Cardoneanu, A., Burlui, A., Luca, A., Codreanu, C., Tamba, B.-I., Stanciu, G. D., Dima, N., Badescu, C. M., & Rezuș, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030614 · Cited by 129
“A direct link between senescent cells and age-related systemic diseases [atherosclerosis, osteoarthritis] has been demonstrated by in vivo studies that have revealed these cells in the affected tissues [32,93].”
MicroRNAs in vascular aging and atherosclerosis
Menghini, R., Stöhr, R., & Federici, M. (2014) · Ageing Research Reviews · doi:10.1016/j.arr.2014.03.005 · Cited by 125
The Role of Sirtuin1 in Regulating Endothelial Function, Arterial Remodeling and Vascular Aging
Man, A. W. C., Li, H., & Xia, N. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.01173 · Cited by 126
Muñoz-Nájar, U., & Sedivy, J. M. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3250 · Cited by 127
“Cells expressing senescence markers are also found at sites of chronic age-related pathologies, such as osteoarthritis and atherosclerosis (34, 141, 217) (Fig.”
Anisimov, V. N. (2007) · Cancer Control · doi:10.1177/107327480701400104 · Cited by 137
Transcriptional expression profiles of oral squamous cell carcinomas
Méndez, E., Cheng, C. K., Farwell, D. G., Ricks, S., Agoff, S. N., Futran, N. D., Weymuller, E. A., Maronian, N. C., Zhao, L. P., & Chen, C. (2002) · Cancer · doi:10.1002/cncr.10875 · Cited by 115
Premature senescence of human endothelial cells induced by inhibition of glutaminase
Unterluggauer, H., Mazurek, S., Lener, B., Hütter, E., EIGENBRODT, E., Zwerschke, W., & Jansen‐Dürr, P. (2008) · Biogerontology · doi:10.1007/s10522-008-9134-x · Cited by 115
“2006), the vascular system (Vasile et al. 2001) and the kidney (Melk et al.”
BackgroundImplications of time-series gene expression profiles of replicative senescence.
Kim, Y., Byun, H., Jee, B. A., Cho, H., Seo, Y., Kim, Y., Park, M. H., Chung, H., Woo, H. G., & Yoon, G. (2013) · Aging Cell · doi:10.1111/acel.12087 · Cited by 106
Scarless wound healing: From development to senescence
Pratsinis, H., Mavrogonatou, E., & Kletsas, D. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.04.011 · Cited by 103
Targeting Senescent Cells in Fibrosis: Pathology, Paradox, and Practical Considerations
Schafer, M. J., Haak, A. J., Tschumperlin, D. J., & LeBrasseur, N. K. (2018) · Current Rheumatology Reports · doi:10.1007/s11926-018-0712-x · Cited by 110
Cellular Senescence and Iron Dyshomeostasis in Alzheimer’s Disease
Masaldan, S., Belaidi, A. A., Ayton, S., & Bush, A. I. (2019) · Pharmaceuticals · doi:10.3390/ph12020093 · Cited by 109
Comparison of early passage, senescent and hTERT immortalized endothelial cells
Chang, M. W.-F., Grillari, J., Mayrhofer, C., Fortschegger, K., Allmaier, G. M., Marzban, G., Katinger, H. W. D., & Voglauer, R. (2005) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.05.002 · Cited by 111
“Since senescent endothelial cells have been identified to be present in vivo [76] and especially in atherosclerotic lesions [77,78], the in vivo relevance of replicative senescence has been dramatically increased.”
BackgroundMechanisms of endothelial senescence
Erusalimsky, J. D., & Skene, C. (2008) · Experimental Physiology · doi:10.1113/expphysiol.2008.043133 · Cited by 109
“Following our work, other laboratories have used SA-β-gal to demonstrate the presence of senescent endothelial cells overlying atherosclerotic plaques of human aorta and coronary arteries (Vasile et al. 2001; Minamino et al. 2002) and in the aortae of diabetic rats (Chen et al. 2002).”
MethodWRN at telomeres: implications for aging and cancer
Multani, A. S., & Chang, S. (2007) · Journal of Cell Science · doi:10.1242/jcs.03397 · Cited by 95
“For example, SA- -gal-positive senescent cells have been identified in aged liver, atherosclerotic plaques, and skin (Dimri et al., 1995; Vasile et al., 2001).”
BackgroundLowe, D., & Raj, K. (2014) · Aging Cell · doi:10.1111/acel.12253 · Cited by 102
Cellular Senescence and Tissue Aging In Vivo
Hornsby, P. J. (2002) · The Journals of Gerontology Series A · doi:10.1093/gerona/57.7.b251 · Cited by 100
Little, M. P., Azizova, T. V., & Hamada, N. (2021) · International Journal of Radiation Biology · doi:10.1080/09553002.2021.1876955 · Cited by 107
“2014), and senescence is known to be associated with atherosclerotic lesions (Vasile et al. 2001; Minamino et al. 2002).”
BackgroundKreuzer, M., Auvinen, A., Cardis, E., Hall, J., Jourdain, J.-R., Laurier, D., Little, M. P., Peters, A., Raj, K., Russell, N. S., et al. (2015) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2015.03.002 · Cited by 86
Cellular senescence: Implications for metabolic disease
Schafer, M. J., Miller, J. D., & LeBrasseur, N. K. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.08.047 · Cited by 92
“In aged or diseased cardiovascular tissues, however, numerous studies have reported increases in markers of senescent cells, including p16INK4a [30,115], SA- βgal [116,117], and TAF [118].”
Backgroundden Buijs, J. O., Musters, M., Verrips, T. C., Post, J. A., Braam, B. G., & van Riel, N. A. W. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00332.2004 · Cited by 86
Cellular Senescence and Vascular Disease: Novel Routes to Better Understanding and Therapy
Yin, H., & Pickering, J. G. (2016) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2016.02.051 · Cited by 82
Venkatesh, D., Fredette, N. C., Rostama, B., Tang, Y., Vary, C., Liaw, L., & Urs, S. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.221945 · Cited by 86
Implications of Oxidative Stress and Cellular Senescence in Age-Related Thymus Involution
Barbouti, A., Vasileiou, P. V. S., Evangelou, K., Vlasis, K. G., Papoudou‐Bai, A., Gorgoulis, V. G., & Kanavaros, P. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/7986071 · Cited by 90
Kurz, D. J., Hong, Y., Trivier, E., Huang, H.-L., Decary, S., Zang, G. H., Lüscher, T. F., & Erusalimsky, J. D. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000069624.55424.61 · Cited by 83
Sun, Y., Hu, X., Hu, G., Xu, C., & Jiang, H. (2015) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b15-00012 · Cited by 86
HAMPEL, B., FORTSCHEGGER, K., RESSLER, S., CHANG, M., UNTERLUGGAUER, H., BREITWIESER, A., SOMMERGRUBER, W., FITZKY, B., LEPPERDINGER, G., & JANSENDURR, P. (2006) · Experimental Gerontology · doi:10.1016/j.exger.2006.03.001 · Cited by 78
Efficacy and age-related effects of nitric oxide-releasing aspirin on experimental restenosis
Claudio Napoli, A., Aldini, G., Wallace, J. L., de Nigris, F., Maffei, R., Abete, P., Bonaduce, D., Condorelli, G., Rengo, F., Sica, V., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.022639399 · Cited by 75
Hughes, M., McGettrick, H. M., & Sapey, E. (2020) · European Respiratory Review · doi:10.1183/16000617.0102-2019 · Cited by 85
Cellular senescence: a hitchhiker’s guide
Aravinthan, A. D. (2015) · Human Cell · doi:10.1007/s13577-015-0110-x · Cited by 89
“The presence of senescent cells at sites of age-related pathology corroborates the deleterious effect of cellular senescence in ageing [176-179].”
BackgroundDouville, J. M., Cheung, D. Y. C., Herbert, K. L., Moffatt, T., & Wigle, J. T. (2011) · PLoS ONE · doi:10.1371/journal.pone.0029099 · Cited by 72
“cells [8–10].”
BackgroundIssitt, T., Bosseboeuf, E., de Winter, N., Dufton, N., Gestri, G., Senatore, V., Chikh, A., RANDI, A. M., & Raimondi, C. (2018) · iScience · doi:10.1016/j.isci.2018.12.005 · Cited by 76
“In the aging cardiovasculature, senescent ECs accumulate in atherosclerotic lesions and likely contribute to disease progression by creating a pro-inflammatory and pro-thrombotic environment (Minamino et al., 2002; Vasile et al., 2001; Warboys et al., 2014).”
BackgroundRelationships between cancer and aging: a multilevel approach
Anisimov, V. N., Sikora, E., & Pawelec, G. (2009) · Biogerontology · doi:10.1007/s10522-008-9209-8 · Cited by 77
Li, G., Luna, C., Qiu, J., Epstein, D. L., & González, P. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.09-4874 · Cited by 75
Premature aging/senescence in cancer cells facing therapy: good or bad?
Calvo, L., Ghadaouia, S., Martinez, A., & Rodier, F. (2015) · Biogerontology · doi:10.1007/s10522-015-9593-9 · Cited by 82
“2002), arthritic joints and atherosclerosis (Fenton et al. 2001; Vasile et al. 2001), skin ulcers and liver cirrhosis (Wiemann et al.”
BackgroundBand, M. R., Olmstead, C. A., Everts, R. E., Liu, Z. L., & Lewin, H. A. (2002) · Animal Biotechnology · doi:10.1081/abio-120005779 · Cited by 70
“Additional genes overexpressed in placenta include PLC , a regulator of mammary growth, TMSB10 , shown to be highly expressed in tumor blood vessels and significantly down-regulated in senescent cells [19] and nine “novel genes” whose difference in expression ratios range from 2- to 17-fold.”
Backgroundvan Heemst, D., den Reijer, P. M., & Westendorp, R. G. J. (2007) · European Journal of Cancer · doi:10.1016/j.ejca.2007.07.011 · Cited by 87
Hadri, K. E., Smith, R., Duplus, E., & Amri, C. E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010077 · Cited by 76
Davis, T., & Kipling, D. (2006) · Rejuvenation Research · doi:10.1089/rej.2006.9.402 · Cited by 71
“402 age, 6–12 and modulations that lengthen life-Department M capable of only a finite number of divisions, after which they enter a state of viable growth arrest termed replicative senescence.”
Protective Effects of Triphala on Dermal Fibroblasts and Human Keratinocytes
Varma, S. R., Sivaprakasam, T. O., Mishra, A., Kumar, L. M. S., Prakash, N. S., Prabhu, S. V., & Ramakrishnan, S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0145921 · Cited by 76
“Cellular senescence is an indication of age-associated etiology [58].”
BackgroundAging and Survival of Cutaneous Microvasculature
Chang, E., Yang, J., Nagavarapu, U., & Herron, G. S. (2002) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2002.01714.x · Cited by 70
Cell Senescence, Multiple Organelle Dysfunction and Atherosclerosis
Machado-Oliveira, G., Ramos, C., Marques, A. R. A., & Vieira, O. V. (2020) · Cells · doi:10.3390/cells9102146 · Cited by 80
“Specifically, senescent cells have been found to accumulate in sites of atherosclerosis ex vivo in human samples [29,30], again suggesting the involvement of cell senescence in sculpting this disease.”
BackgroundSenescence in tissue samples of humans with age-related diseases: A systematic review
Tuttle, C. S. L., Luesken, S. W. M., Waaijer, M. E. C., & Maier, A. B. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101334 · Cited by 74
“Heart Overall, 27/103 articles focused on diseases of the heart with atherosclerosis (8/27) (Abbas et al., 2017; Eo et al., 2011; Gardner et al., 2015; Lv et al., 2017; Matsumoto et al., 2009; Matthews et al., 2006; Minamino et al., 2002; Vasile et al., 2001) and coronary artery disease (7/27) (Chan et al.”
Roles of Thymosins in Cancers and Other Organ Systems
Chen, C., Li, M., Yang, H., Chai, H., Fisher, W. P., & Yao, Q. C. (2005) · World Journal of Surgery · doi:10.1007/s00268-004-7817-2 · Cited by 65
Hypoxia driven glycation: Mechanisms and therapeutic opportunities
Khan, M. I., Rath, S., Adhami, V. M., & Mukhtar, H. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.05.008 · Cited by 75
Micro RNA ‐214‐3p: A link between autophagy and endothelial cell dysfunction in atherosclerosis
Wang, J., Wang, W. ‐., Xu, S., Wu, H., Dai, B., Jian, D., Yang, M., Wu, Y. ‐., Feng, Q., Zhu, J., et al. (2017) · Acta Physiologica · doi:10.1111/apha.12973 · Cited by 67
p53 plays a crucial role in endothelial dysfunction associated with hyperglycemia and ischemia
Yokoyama, M., Shimizu, I., Nagasawa, A., Yoshida, Y., Katsuumi, G., Wakasugi, T., Hayashi, Y., Ikegami, R., Suda, M., Ota, Y., et al. (2019) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2019.02.010 · Cited by 64
Rombouts, C., Aerts, A., Quintens, R., Baselet, B., Saghire, H. E., Harms‐Ringdahl, M., Haghdoost, S., Janssen, A., Michaux, A., Yentrapalli, R., et al. (2014) · International Journal of Radiation Biology · doi:10.3109/09553002.2014.905724 · Cited by 67
Osteopontin Stimulates Preneoplastic Cellular Proliferation Through Activation of the MAPK Pathway
Luo, X., Ruhland, M. K., Pazolli, E., Lind, A. C., & Stewart, S. A. (2011) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-10-0472 · Cited by 62
Dreyfuss, J. M., Johnson, M. D., & Park, P. J. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-71 · Cited by 65
“TMSB10 can also be regulated by VEGF [57].”
Chen, H., Wan, Y.-Z., Zhou, S., Lu, Y., Zhang, Z., Zhang, R., Chen, F., Hao, D., Zhao, X., Guo, Z.-C., et al. (2012) · Science China Life Sciences · doi:10.1007/s11427-012-4329-4 · Cited by 59
Tsirpanlis, G. I. (2008) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2007.07.035 · Cited by 59
Sun, X., & Feinberg, M. W. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.693067 · Cited by 58
Regulation of Senescence in Cancer and Aging
Kong, Y., Cui, H., Ramkumar, C., & Zhang, H. (2011) · Journal of Aging Research · doi:10.4061/2011/963172 · Cited by 68
Metadata
- Authors
- VASILE, E., TOMITA, Y., BROWN, L. F., KOCHER, O., & DVORAK, H. F.
- Affiliations
- Beth Israel Deaconess Medical Center (US)
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2001-02
- Volume
- 15
- Issue
- 2
- Pages
- 458-466
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W1989335335
- Cited by
- 232
- References
- 54
- Citations by year
- 2026: 3 · 2025: 7 · 2024: 1 · 2023: 4 · 2022: 7 · 2021: 13 · 2020: 6 · 2019: 10 · 2018: 8 · 2017: 9 · 2016: 8 · 2015: 13 · 2014: 9 · 2013: 5 · 2012: 7
- FWCI
- 6.97
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The FASEB Journal (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (CA‐50453, HL‐54465)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Keywords
- thymosin beta 10, endothelial cell senescence, vascular endothelial growth factor, gene expression profiling, atherosclerosis, senescence-associated β-galactosidase, actin dynamics, tumor vasculature, endothelial plasticity, replicative senescence
- MeSH terms
- Actins, Adenocarcinoma, Aorta, Thoracic, Arteriosclerosis, Cells, Cultured, Colonic Neoplasms, Endothelium, Vascular, Gene Expression Regulation, Humans, Infant, Newborn, Lymphokines, Male, Microcirculation, RNA, Messenger, Skin, Thymosin, Transcription, Genetic, Endothelial Growth Factors, Cellular Senescence, DNA, Complementary, Vascular Endothelial Growth Factors, Vascular Endothelial Growth Factor A
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.